In addition to drawing faculty from a variety of departments and schools around the university, NEIDL investigators collaborate widely with faculty from other research centers.
These collaborations promote innovation in emerging infectious diseases research within NEIDL.
In the News
-
After 30 years of decline, tuberculosis is rising in the U.S. again. How did we get here?
After declining for three decades, tuberculosis (TB) rates in the U.S. have been increasing steadily since 2020.
-
Is COVID-19 Still a Pandemic?
The Brink asked three Boston University researchers—a virologist, an epidemiologist, and an emergency room physician—to explain the shifting status of COVID, how to decide when a virus has gone from a pandemic to endemic, how much people should protect themselves and others, and why language matters.
-
Novel compound protects against infection by virus that causes COVID-19, preliminary studies show.
Compounds that obstruct the “landing gear” of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19 finds a new study from NEIDL researchers and the Dana-Farber Cancer Institute.